APA (7th ed.) Citation

Kette, S., Reccardini, N., Salton, F., Confalonieri, P., Andrisano, A., Chianese, M., . . . Ruaro, B. (2025). The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis. Pharmaceuticals (14248247), 18(3), 411. https://doi.org/10.3390/ph18030411

Chicago Style (17th ed.) Citation

Kette, Stefano, et al. "The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis." Pharmaceuticals (14248247) 18, no. 3 (2025): 411. https://doi.org/10.3390/ph18030411.

MLA (9th ed.) Citation

Kette, Stefano, et al. "The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis." Pharmaceuticals (14248247), vol. 18, no. 3, 2025, p. 411, https://doi.org/10.3390/ph18030411.